Second patient dies in France's artificial heart trial

May 4, 2015

The second person in France to receive a much-hyped new-generation artificial heart has died eight months after receiving the transplant, biomedical firm Carmat said Tuesday.

The 69-year-old man, who wished to remain anonymous, was terminally ill when he received the experimental that was seen as a long-term solution for with end-stage .

Carmat, which designed what it calls the world's most-advanced artificial heart, said the patient was admitted to hospital on Friday with "circulatory collapse".

A medical team noted the heart was not functioning correctly and transplanted a new device, however the patient died on Saturday from post-operative complications.

Artificial hearts have been in use for many years as a temporary fix for patients with chronic heart problems.

However Carmat hopes to provide a longer-term solution to tens of thousands who suffer from —the world's leading cause of death—and are unable to receive a transplant.

The device, a self-contained unit implanted in a patient's chest, is a mix of synthetic materials and animal tissue, and seeks to mimic the form and function of an actual .

The artificial heart uses soft biomaterials intended to lessen the risk of blood clots and rejection by the immune system. It is powered by a belt of lithium batteries.

Carmat's first trial of the device on a 76-year-old man ended March 2 with the patient's death after two and a half months.

The second patient said in an interview with French media a month ago that he had "recovered" to the point of going on bike rides.

Nearly 100,000 people in Europe and the United States are in need of a , according to Carmat, but only about 4,000 hearts become available for transplant.

The French firm's trial was to involve four people. A third patient was confirmed to have received their last week.

The first phase of the trial will be considered a success if patients survive for a month after the transplant. Carmat will then carry out a second phase of clinical trials which will involve 20 patients.

Explore further: France's second artificial heart recipient says 'recovered'

Related Stories

France's second artificial heart recipient says 'recovered'

April 5, 2015
A man who in August became the second person in France to receive a much-hyped new-generation artificial heart said in his first interview Sunday he had "recovered", to the point of going on bike rides.

France's second artificial heart recipient 'doing well'

October 28, 2014
A man who in August became the second person in France to receive a new-generation artificial heart "is doing very well," the inventor of the pioneer device said Tuesday.

Trial continues after patient death: French heartmaker

March 4, 2014
French biomedical firm Carmat said Tuesday it would implant its experimental artificial heart into another three people, as planned, after the first recipient died.

Second artificial heart implant due in 'weeks'

March 17, 2014
After its first recipient died, French biomedical firm Carmat said on Monday it expected to try again to implant its experimental artificial heart in another patient "in several weeks".

France announces second artificial heart transplant

September 8, 2014
France last month carried out the second transplant of a new-generation artificial heart, Health Minister Marisol Touraine said Monday.

Man with first artificial heart dies after 75 days

March 3, 2014
A septuagenarian man who was fitted with the French biomedical firm Carmat's first artificial heart two and half months ago has died, a hospital statement said Monday.

Recommended for you

To have or not to have... your left atrial appendage closed

May 22, 2018
Each year in the U.S., more than 300,000 people have heart surgery. To reduce risk of stroke for their patients, surgeons often will close the left atrial appendage, which is a small sac in the left side of the heart where ...

Natural antioxidant bilirubin may improve cardiovascular health

May 18, 2018
Bilirubin, a yellow-orange pigment, is formed after the breakdown of red blood cells and is eliminated by the liver. It's not only a sign of a bruise, it may provide cardiovascular benefits, according to a large-scale epidemiology ...

New algorithm more accurately predicts life expectancy after heart failure

May 17, 2018
A new algorithm developed by UCLA researchers more accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more ...

New genes found that determine how the heart responds to exercise

May 17, 2018
A new study by researchers at Queen Mary University of London and University College London (UCL) has discovered 30 new gene locations that determine how the heart responds to and recovers from exercise.

Novel therapy inhibits complement to preserve neurons and reduce inflammation after stroke

May 16, 2018
A team of investigators at the Medical University of South Carolina (MUSC) has developed a novel therapy for ischemic (clot-caused) stroke and has shown in a preclinical model that it locally inhibits complement at and around ...

Greater burden of atrial fibrillation linked to higher stroke risk

May 16, 2018
Among people with intermittently recurring atrial fibrillation who are not taking anti-blood-clotting medications, those whose hearts were in abnormal rhythms longer were three times more likely to have strokes or other types ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.